The Nuclear Imaging Equipment Market, estimated at USD 3.57 Bn in 2025, is expected to exhibit a CAGR of 5.1% and reach USD 5.06 Bn by 2032.
The industry is witnessing significant growth driven by rising demand for advanced, reliable, and cost-effective medical devices across diagnostic, therapeutic, and monitoring applications. Rapid advancements in device design, digital health integration, and adoption of minimally invasive technologies are reshaping the competitive landscape. Furthermore, supportive regulatory frameworks, increasing healthcare investments, and the growing focus on patient-centric care are expected to create new growth avenues for market players.
Key market players are focusing on adoption of growth strategies such as launch of new products, and this is expected to drive the global nuclear imaging equipment market growth. For instance, on June 12, 2025, Siemens Healthineers, a Germany-based company that provides healthcare solutions and services, introduced Symbia Pro.specta, a single photon emission computed tomography/computed tomography (SPECT/CT) system with CE mark and Food and Drug Administration (FDA) clearance that has advanced SPECT and CT imaging technologies.
Global Nuclear Imaging Equipment Market– Impact of Coronavirus (COVID-19) Pandemic
The World Health Organization (WHO) designated the illness caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), which first appeared in Wuhan (province of Hubei, China), in the last months of 2025, as "coronavirus disease 2025" or COVID-19. This virus spreads quickly, and had a serious negative impact on the economies, social behaviors, and healthcare of every country in the world.
COVID-19 affected the economy in three main ways: by directly affecting production and demand, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to the lockdown, several countries such as India, China, Brazil, and others faced problems regarding transportation of things from one place to another.
COVID-19 had a negative impact on the global nuclear imaging equipment market. For instance, on April 6, 2025, according to the data published by the National Center for Biotechnology Information (NCBI), hospital patient volumes decreased during the beginning stages of the pandemic in multiple medical disciplines including radiology, emergency, and surgery departments. The American Hospital Association estimated that between March and June 2025, American hospitals lost on average US$ 50.7 billion per month. The decrease in overall patient volumes led to decreased need for imaging within hospital systems. Consequently, both imaging volumes and revenue generation were lower during the initial stages of the COVID-19 pandemic.